Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
Location: United States, California, San Diego
Employees: 51-200
Total raised: $430M
Founded date: 2017
Investors 5
| Date | Name | Website |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | Omega Fund... | omegafunds... |
| - | EcoR1 Capi... | ecor1cap.c... |
| - | Altitude L... | altitudels... |
| - | Bay City C... | baycitycap... |
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 24.07.2018 | Series B | $230M | - | medcitynew... |
| 05.01.2018 | Seed | $100M | - | vcnewsdail... |
| 05.01.2018 | Series A | $100M | - | socaltech.... |
Mentions in press and media 13
| Date | Title | Description | Source |
| 25.02.2021 | Gossamer Bio Announces Fourth Quarter and Full-Year 2020 Fin... | SAN DIEGO--(BUSINESS WIRE)--Feb 25, 2021-- Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biop... | oaoa.com/n... |
| 08.02.2019 | Gossamer Bio becomes 2019’s second biotech ‘unicorn’ to go p... | Gossamer is the second “unicorn” – a company with a value of at least $1 billion – to go public this... | medcitynew... |
| 24.07.2018 | Gossamer Bio secures $230 million in Series B funding round | The company was founded by former Receptos executives Faheem Hasnain and Sheila Gujrathi. Hasnain, w... | medcitynew... |
| 24.07.2018 | Hillhouse Capital leads $230m Series B in US-based Gossamer ... | Premium Beijing and Hong Kong-based Hillhouse Capital has led a $230-million Series B in Gossamer B... | dealstreet... |
| 23.07.2018 | Gossamer Bio nets $230M in series B to advance portfolio aga... | Gossamer Bio netted $230 million in a series B financing round—on the heels of its $100 million laun... | fiercebiot... |
| 23.07.2018 | Gossamer Bio Gains $230M | San Diego-based Gossamer Bio, a biotechnology company focused on therapeutics in the autoimmune, all... | socaltech.... |
| 23.07.2018 | Gossamer Bio nets $230M in series B to advance portfolio aga... | Gossamer Bio netted $230 million in a series B financing round—on the heels of its $100 million laun... | fiercebiot... |
| 06.01.2018 | Gossamer Bio Raises $100M in Series A Funding | Gossamer Bio, Inc., a San Diego, CA-based new biopharmaceutical company focused on the discovery and... | finsmes.co... |
| 05.01.2018 | Gossamer Bio Raises $100M | San Diego-based Gossamer Bio, a new biopharma startup founded by former executives of Receptos, has ... | socaltech.... |
| 05.01.2018 | Term Sheet — Friday, January 5 | THE BILLIONAIRE CLUB Happy Friday, Term Sheet readers! Paid Content Securing the enterprise withou... | fortune.co... |
Show more